ANGO logo

ANGO
Angiodynamic Inc

1,062
Mkt Cap
$417.95M
Volume
953,889.00
52W High
$13.99
52W Low
$8.27
PE Ratio
-14.65
ANGO Fundamentals
Price
$9.86
Prev Close
$10.05
Open
$9.98
50D MA
$12.52
Beta
1.01
Avg. Volume
400,997.14
EPS (Annual)
-$0.8321
P/B
2.32
Rev/Employee
$433,330.37
Loading...
Loading...
News
all
press releases
ANGO Stock Dips Despite Q2 Earnings Beat, Gross Margin Improves
AngioDynamics reports flat Q2 earnings while revenue increase 8.8% and gross margin expands 170 bps on stronger Med Tech performance.
Zacks·3d ago
News Placeholder
More News
News Placeholder
AngioDynamics (ANGO) Q1 2026 Earnings Transcript
@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...
Nasdaq News: Markets·4d ago
News Placeholder
AngioDynamics (ANGO) Q3 2025 Earnings Transcript
@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...
Nasdaq News: Markets·4d ago
News Placeholder
AngioDynamics (ANGO) Q1 2025 Earnings Transcript
@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...
Nasdaq News: Markets·4d ago
News Placeholder
AngioDynamics (ANGO) Q2 2026 Earnings Transcript
@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...
Nasdaq News: Markets·4d ago
News Placeholder
AngioDynamics (NASDAQ:ANGO) Issues Quarterly Earnings Results
AngioDynamics (NASDAQ:ANGO - Get Free Report) posted its earnings results on Tuesday. The medical instruments supplier reported ($0.15) earnings per share for the quarter, missing the consensus...
MarketBeat·4d ago
News Placeholder
Why AngioDynamics Stock Is Sinking Today
Key PointsThe medical technology company announced the retirement of CEO Jim Clemmer...
Nasdaq News: Markets·4d ago
News Placeholder
AngioDynamics Q2 Earnings Call Highlights
AngioDynamics (NASDAQ:ANGO) reported fiscal 2026 second-quarter results that management said reflected strong execution across the portfolio, with revenue growth and improved profitability. On the...
MarketBeat·4d ago
News Placeholder
AngioDynamics (NASDAQ:ANGO) Releases FY 2026 Earnings Guidance
AngioDynamics (NASDAQ:ANGO) updated its FY 2026 earnings guidance. The company provided EPS guidance of -0.330--0.230 for the period, compared to the consensus estimate of -0.310. The company also...
MarketBeat·4d ago
News Placeholder
AngioDynamics Reports Fiscal Year 2026 Second Quarter Financial Results; Continued Double Digit Med Tech Growth Drives Increased Profitability
AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the bodys vascular system, expanding cancer treatment options...
Business Wire·4d ago
<
1
2
...
>

Latest ANGO News

View

Advertisement|Remove ads.

Advertisement|Remove ads.